Intercure Ltd. (INCR) stock
INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.46−0.11 (-2.41%)
Close on Oct 19, 2026
Intercure net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was -35.71M ILS. The highest annual figure on record is 44.82M ILS in fiscal 2022.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -35.71M ILS | – |
| FY2024 | Dec 31, 2024 | -67.80M ILS | – |
| FY2023 | Dec 31, 2023 | -61.96M ILS | -238.2% |
| FY2022 | Dec 31, 2022 | 44.82M ILS | +855.6% |
| FY2021 | Dec 31, 2021 | 4.69M ILS | – |
| FY2020 | Dec 31, 2020 | -37.23M ILS | – |
| FY2019 | Dec 31, 2019 | -5.89M ILS | – |
See a number that looks wrong?